Mackay Shields LLC’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,138
| Closed | -$1.77M | – | 300 |
|
|
2022
Q1 | $1.77M | Sell |
3,138
-127
| -4% | -$71.5K | 0.02% | 580 |
|
|
2021
Q4 | $2.47M | Sell |
3,265
-70
| -2% | -$52.9K | 0.02% | 526 |
|
|
2021
Q3 | $2.49M | Sell |
3,335
-96
| -3% | -$71.6K | 0.02% | 500 |
|
|
2021
Q2 | $2.21M | Sell |
3,431
-287
| -8% | -$185K | 0.02% | 521 |
|
|
2021
Q1 | $2.12M | Sell |
3,718
-21
| -0.6% | -$12K | 0.02% | 748 |
|
|
2020
Q4 | $2.18M | Sell |
3,739
-550
| -13% | -$321K | 0.02% | 821 |
|
|
2020
Q3 | $2.21M | Buy |
4,289
+221
| +5% | +$114K | 0.02% | 745 |
|
|
2020
Q2 | $1.84M | Buy |
+4,068
| New | +$1.84M | 0.01% | 792 |
|
|
2019
Q4 | – | Sell |
-1,946
| Closed | -$648K | – | 1356 |
|
|
2019
Q3 | $648K | Buy |
+1,946
| New | +$648K | ﹤0.01% | 1211 |
|
|
2018
Q3 | – | Sell |
-2,661
| Closed | -$768K | – | 1156 |
|
|
2018
Q2 | $768K | Sell |
2,661
-10,681
| -80% | -$3.08M | 0.01% | 1021 |
|
|
2018
Q1 | $3.34M | Buy |
+13,342
| New | +$3.34M | 0.02% | 635 |
|